Brief: Synact Pharma Shares In Directed Issue At Subscription Price Of SEK 16 Per Share
June 4 (Reuters) - SynAct Pharma AB SYNACT.ST: SHARES IN DIRECTED ISSUE ARE ISSUED AT A SUBSCRIPTION PRICE OF SEK 16 PER SHARE CARRIES OUT A DIRECTED SHARE ISSUE OF SEK 37 MILLION AND EXTENDS ITS FINANCIAL RUNWAY TO END OF 2026 SHARES ISSUED AT SUBSCRIPTION PRICE OF SEK 16 PER SHARE DIRECTED ISSUE TO PROVIDE ABOUT SEK 37 MILLION BEFORE COSTS Source text: ID:nMFN77rdT Further company coverage: SYNACT.ST (Gdansk Newsroom) ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on SynAct Pharma AB
See all newsBrief: SynAct: Shareholding Board, Management Sign Lock-Up Agreements
Sweden's SynAct Pharma posts wider Q1 net loss as expenses rise
Brief: SynAct Pharma Q1 Sales SEK 0
Brief: SynAct Pharma Carries Out Directed Issue Of New Shares
Brief: Synact Pharma Appoints Ann Kristin Led As CFO Effective March 2026